Northwell Health - Feinstein Institute for Medical Research

Summer 2017

Issue link: http://viewer.e-digitaledition.com/i/858493

Contents of this Issue

Navigation

Page 1 of 7

In one of this year's most popular panels at the SXSW Interactive Festival, America's premier festival of technological and scientific innovation, Feinstein Institute researchers discussed the current clinical trials and future applications in the emerging field of bioelectronic medicine with colleagues from other leading research institutions. Chad Bouton, director of the Center for Bioelectronic Medicine and vice president of advanced engineering at Nothwell Health, had an open dialogue with thought leaders from the Massachusetts Institute of Technology and the Defense Advanced Research Projects Agency as part of the panel, "The Future Body: Modulating the Nervous System." "The SXSW Interactive Festival is rightly celebrated as one of the best venues for showcasing innovation in a wide array of fields and disciplines, including health care," Mr. Bouton said. "We believe few breakthroughs have greater capacity to have an impact on millions of lives than the research being conducted in the field of bioelectronic medicine." Visit 4healthier.me/NWSD-SXSW to watch the panel. and Researchers join innovators at top tech conference Welcome to the Summer/Fall 2017 edition of Science + Discovery, a publication celebrating the pioneering work of the Feinstein Institute for Medical Research. In these pages, we invite you to examine recent developments taking place at the Feinstein Institute, including new applications for existing medications, greater understanding of the way your genes can be used to combat various conditions including cancer and advances in the field of bioelectronic medicine with the potential to affect the lives of millions. Join us on our journey to push the boundaries of medical discovery and learn more about how your support makes progress possible. our partners in bioelectronic medicine Two new alliances have the potential to transform the way injuries and diseases are treated. Welcome Welcome to the Welcome Welcome to the Summer/Fall 2017 edition of Welcome Summer/Fall 2017 edition of Science + Discovery Welcome Science + Discovery, a publication celebrating Welcome , a publication celebrating of the way your genes can be used to combat Welcome of the way your genes can be used to combat various conditions including cancer and Welcome various conditions including cancer and The Center for Bioelectronic Medicine has entered into strategic partnerships with GE Ventures and United Therapeutics (UT) to further strengthen and support the development of bioelectronic medicine therapies. The venture capital branch of General Electric, GE Ventures partners with organizations around the world that are making strides in industries, including health care. The GE Ventures- Feinstein Institute alliance brings together Feinstein Institute researchers and GE Global Research Center scientists to develop new therapies for a range of illnesses, including cancer, diabetes and neurodegenerative disorders. "GE's collaboration with the Feinstein Institute brings critical mass to our efforts in terms of resources, know-how and partnerships," said Chad Bouton, director of the Center for Bioelectronic Medicine and vice president of advanced engineering at Northwell Health. "In just a few years, we will look back on this agreement as the moment when bioelectronic medicine took off." Expanding bioelectronic medicine targets Through a collaboration with United Therapeutics, Feinstein Institute researchers will receive funding for four new clinical research endeavors, two of which will be conducted by the Center for Bioelectronic Medicine. These projects will focus on integrating bioelectronic medicine and cell therapy into such fields as cardiology and post-transplant care. "Collaboration is an indispensable factor in successful medical research," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. "With great partners, you can accomplish great things for science and for patients. United Therapeutics is such a partner." 2 / Issue 2 2017 News + events

Articles in this issue

Links on this page

Archives of this issue

view archives of Northwell Health - Feinstein Institute for Medical Research - Summer 2017